RPL32 and lung cancer: Xie et al. found that silencing of RPL32 causes RPL5 and RPL11 to be transferred from the nucleus to the nucleoplasm, leading to the accumulation of p53 and inhibition of lung cancer proliferation (Xie et al., 2020).